Chevy Chase Trust Holdings LLC Has $39.44 Million Position in Cigna Group $CI

Key Points

• Cigna beat quarterly expectations, reporting $8.08 EPS vs. $7.88 expected and $72.5B in revenue vs. $69.53B, set FY‑2026 guidance near $30.25 EPS, and raised its quarterly dividend to $1.56 (annualized $6.24, ~2.3% yield).
• Chevy Chase Trust trimmed its stake by 4% to 136,826 shares worth $39.44M; institutional ownership is ~86.99% while insiders (Nicole S. Jones and Everett Neville) recently sold shares, reducing their holdings.
• Analysts are lifting targets—multiple upgrades and hikes (e.g., Bernstein $358, Jefferies $333, Truist $350) leave an average price target of $333.11 and a consensus rating of "Moderate Buy."

Chevy Chase Trust Holdings LLC decreased its position in shares of Cigna Group (NYSE:CI - Free Report) by 4.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 136,826 shares of the health services provider's stock after selling 5,738 shares during the period. Chevy Chase Trust Holdings LLC owned 0.05% of Cigna Group worth $39,440,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Brighton Jones LLC grew its holdings in Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider's stock valued at $1,032,000 after purchasing an additional 318 shares during the last quarter. Sivia Capital Partners LLC lifted its position in shares of Cigna Group by 10.4% during the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider's stock worth $384,000 after purchasing an additional 109 shares during the last quarter. SBI Securities Co. Ltd. boosted its stake in Cigna Group by 15.1% during the 2nd quarter. SBI Securities Co. Ltd. now owns 458 shares of the health services provider's stock valued at $151,000 after purchasing an additional 60 shares during the period. Intrua Financial LLC bought a new stake in Cigna Group during the 2nd quarter valued at approximately $201,000. Finally, Empower Advisory Group LLC grew its position in Cigna Group by 1.3% in the 2nd quarter. Empower Advisory Group LLC now owns 11,263 shares of the health services provider's stock worth $3,723,000 after purchasing an additional 143 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Cigna Group

In related news, insider Nicole S. Jones sold 2,307 shares of the firm's stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the transaction, the insider directly owned 32,647 shares of the company's stock, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the transaction, the insider owned 5,670 shares of the company's stock, valued at $1,638,119.70. The trade was a 23.26% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

CI has been the subject of several research reports. Mizuho set a $325.00 target price on shares of Cigna Group in a research note on Friday, January 9th. Sanford C. Bernstein raised shares of Cigna Group from a "market perform" rating to an "outperform" rating and boosted their price target for the company from $307.00 to $358.00 in a report on Thursday. Wall Street Zen upgraded Cigna Group from a "hold" rating to a "buy" rating in a research note on Saturday, February 7th. Jefferies Financial Group raised their target price on Cigna Group from $310.00 to $333.00 and gave the stock a "buy" rating in a research report on Monday, February 9th. Finally, Truist Financial upped their price objective on shares of Cigna Group from $320.00 to $350.00 and gave the stock a "buy" rating in a research note on Tuesday, February 17th. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $333.11.

Cigna Group News Summary

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Sanford C. Bernstein upgraded Cigna to "outperform" and raised its price target to $358, citing PBM reform as a clearing event and improved outlook for Evernorth — a catalyst for multiple analysts to raise estimates. Bernstein upgrades CVS and Cigna, citing PBM reform as key clearing event
• Positive Sentiment: Zacks notes CI trades below the industry P/E and highlights Evernorth growth, steady earnings beats and buybacks as supports for the investment case — a valuation/earnings combo that helps explain buying interest. Cigna Stock Trades Below Industry P/E: Is It Worth Holding Now?
• Neutral Sentiment: A valuation review highlights recent share-price weakness versus the specialty-pharmacy growth narrative — useful context for investors weighing whether current discounts already reflect execution risks. Evaluating Cigna Group (CI) Valuation After Recent Share Price Weakness And Specialty Pharmacy Growth Narrative
• Neutral Sentiment: A head-to-head comparison with CVS frames Cigna as the play for stronger earnings quality and capital discipline, while reminding long-term investors to consider income, stability and valuation differences when choosing exposure. CVS vs Cigna: Which Healthcare Giant Belongs in Your Retirement Portfolio?
• Neutral Sentiment: Zacks’ broader industry outlook continues to single out major HMOs (including Cigna) as key players in a sector balancing tech-enabled growth and policy/operational headwinds. Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana and Centene
• Negative Sentiment: Barclays and commentators warn that the timing of a CEO change could surprise investors and introduce strategic/operational uncertainty during a critical execution window. Management transition risk may weigh on sentiment until plans are clearer. The Cigna Group (CI) CEO Change Timing May Come As Surprise to Some Investors, According to Barclays
• Negative Sentiment: Industry pieces flag escalating medical costs, nursing shortages and margin pressure as sector-wide risks that could blunt near-term earnings leverage for HMOs, including Cigna. 4 HMO Stocks to Watch Despite Escalating Costs, Nursing Shortage

Cigna Group Trading Up 0.5%

Shares of NYSE CI opened at $267.15 on Monday. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00. The company's fifty day moving average is $279.60 and its 200-day moving average is $282.70. The stock has a market cap of $70.40 billion, a price-to-earnings ratio of 12.04, a P/E/G ratio of 0.93 and a beta of 0.27.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating the consensus estimate of $7.88 by $0.20. The company had revenue of $72.50 billion during the quarter, compared to analysts' expectations of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business's quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities research analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be issued a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Thursday, March 5th. This is a positive change from Cigna Group's previous quarterly dividend of $1.51. Cigna Group's dividend payout ratio is 28.13%.

Cigna Group Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.